Literature DB >> 1645550

Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level.

C Balsano1, M L Avantaggiati, G Natoli, E De Marzio, H Will, M Perricaudet, M Levrero.   

Abstract

The products of the human hepatitis B virus (HBV) and woodchuck hepatitis B virus X genes (pXs) transactivate homologous and heterologous genes including the HBV-X and core promoters, the human immunodeficiency viruses 1 (HIV-1) and 2 (HIV-2) long terminal repeats and the beta interferon regulatory sequences. We report here that pX is also able to influence the expression of both extrachromosomal transfected c-myc regulatory sequences and endogenous c-myc gene. pX acts by increasing transcription of the c-myc gene and do not affect c-myc mRNAs stability. The presence of the first AUG of the X-ORFs is indeed necessary for the production of an active pX. The very carboxyterminus of the pX protein is dispensable for this transactivating activity and at least one domain important for its action is located between aminoacids 103 and 117.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645550     DOI: 10.1016/0006-291x(91)90379-l

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Possible mechanism for hepatitis B virus X gene to induce apoptosis of hepatocytes.

Authors:  Sheng-Jun Zhang; Hong-Ying Chen; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

5.  Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

Authors:  R Repp; C Keller; A Borkhardt; A Csecke; S Schaefer; W H Gerlich; F Lampert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 6.  Molecular targeted therapy for hepatocellular carcinoma: current and future.

Authors:  Jung Woo Shin; Young-Hwa Chung
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

7.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene.

Authors:  Hyun Jin Kwun; Kyung Lib Jang
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

10.  Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells.

Authors:  Lian Yang; Jun He; Libo Chen; Guobin Wang
Journal:  Med Oncol       Date:  2008-12-13       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.